Targeted tumor coating with antigenic, CTL-recognizable peptides via Annexin A5 chimeric constructs following chemotherapy redirects adaptive CD8+ T cell immunity for tumor clearance

Cell Mol Immunol. 2021 Jun;18(6):1578-1580. doi: 10.1038/s41423-020-00563-x. Epub 2020 Nov 2.

Tae Heung Kang^#¹, Andrew Yang^#^{2

3

4}, Yachea Tsai⁴, Louise Ferrall⁴, Chien-Fu Hung^{5

6}

¹ Institute of Biomedical Science and Technology, Konkuk University, Seoul, South Korea.
² Genetics and Genomics Graduate Program, Baylor College of Medicine, Houston, TX, USA.
³ Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, USA.
⁴ Department of Pathology, Johns Hopkins University, Baltimore, MD, USA.
⁵ Department of Pathology, Johns Hopkins University, Baltimore, MD, USA. chung2@jhmi.edu.
⁶ Department of Oncology, Johns Hopkins University, Baltimore, MD, USA. chung2@jhmi.edu.

^# Contributed equally.

No abstract available

Publication types